• Progression-free survival versus post-progression survival and overall survival in WHO grade 2 gliomas 

      Sagberg, Lisa Millgård; Salvesen, Øyvind Olav; Jakola, Asgeir Store; Thurin, Erik; De Dios, Eddie; Nawabi, Noah L.A; Kilgallon, John L.; Bernstock, Joshua D.; Kavouridis, Vasileios; Smith, Timothy R.; Solheim, Ole Skeidsvoll (Journal article; Peer reviewed, 2024)
      Background and purpose: Progression-free survival (PFS) remains to be validated as an outcome measure for diffuse WHO grade 2 gliomas, and knowledge about the relationships between PFS, post-progression survival (PPS), and ...
    • Stable glioma incidence and increased patient survival over the past two decades in Norway: a nationwide registry-based cohort study 

      Skaga, Erlend; Trewin-Nybråten, Cassia Bree; Niehusmann, Pitt; Johannessen, Tom Børge; Marienhagen, Kirsten; Oltedal, Leif; Schipmann, Stephanie; Skjulsvik, Anne Jarstein; Solheim, Ole Skeidsvoll; Solheim, Tora S; Sundstrøm, Terje; Vik-Mo, Einar Osland; Brandal, Petter; Ingebrigtsen, Tor (Journal article; Peer reviewed, 2024)
      Background: Surveillance of incidence and survival of central nervous system tumors is essential to monitor disease burden and epidemiological changes, and to allocate health care resources. Here, we describe glioma incidence ...